We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+7.08%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.36B
AUM Growth
-$71M
Cap. Flow
-$199M
Cap. Flow %
-8.42%
Top 10 Hldgs %
44.44%
Holding
74
New
10
Increased
32
Reduced
22
Closed
10

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$49.8M
2
XLRN
Acceleron Pharma
XLRN
+$19.7M
3
RLYP
RELYPSA INC COM
RLYP
+$16.9M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$14.6M
5
PTCT icon
PTC Therapeutics
PTCT
+$12.9M

Top Sells

Rank Stock Value
1
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$55.6M
2
AGN
Allergan Inc
AGN
+$47.4M
3
GILD icon
Gilead Sciences
GILD
+$43.5M
4
AEGR
Aegerion Pharmaceuticals
AEGR
+$43.1M
5
TMO icon
Thermo Fisher Scientific
TMO
+$40.6M

Sector Composition

Rank Sector Weight
1 Healthcare 89.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMGN
26
DELISTED
Immunogen Inc
IMGN
$38.1M 1.62%
3,218,276
-405,510
-11% -$5.09M
MRK icon
27
Merck
MRK
$324B
$37.9M 1.6%
686,002
-13,577
-2% -$741K
AGN
28
DELISTED
Allergan Inc
AGN
$32.5M 1.38%
192,050
-304,498
-61% -$47.4M
OMED
29
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$32.4M 1.37%
1,392,485
+44,843
+3% +$1.11M
SGNT
30
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$27.4M 1.16%
1,059,306
+20,802
+2% +$462K
AKRX
31
DELISTED
Akorn Inc
AKRX
$25.3M 1.07%
759,643
-1,800
-0.2% -$47.2K
SGEN
32
DELISTED
Seagen Inc. Common Stock
SGEN
$23.4M 0.99%
612,219
+169,400
+38% +$6.4M
RDY icon
33
Dr. Reddy's Laboratories
RDY
$9.82B
$22M 0.93%
2,549,585
+391,525
+18% +$3.29M
BHC icon
34
Bausch Health
BHC
$1.65B
$21.3M 0.9%
168,900
+40,100
+31% +$5.12M
MNTA
35
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$20.2M 0.86%
1,674,140
+563,343
+51% +$6.65M
XLRN
36
DELISTED
Acceleron Pharma
XLRN
$20M 0.85%
+589,053
New +$19.7M
COV
37
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$19.7M 0.83%
218,422
+8,546
+4% +$639K
ICPT
38
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$17.5M 0.74%
73,993
-500
-0.7% -$132K
RLYP
39
DELISTED
RELYPSA INC COM
RLYP
$17.3M 0.73%
+712,973
New +$16.9M
ALGN icon
40
Align Technology
ALGN
$12B
$16.5M 0.7%
294,356
+97,284
+49% +$5.06M
UTHR icon
41
United Therapeutics
UTHR
$26.3B
$16.1M 0.68%
182,400
-52,000
-22% -$5M
ISRG icon
42
Intuitive Surgical
ISRG
$121B
$16.1M 0.68%
350,847
+59,175
+20% +$2.61M
ABBV icon
43
AbbVie
ABBV
$458B
$15.3M 0.65%
271,741
-2,238
-0.8% -$117K
CMRX
44
DELISTED
Chimerix, Inc.
CMRX
$13.9M 0.59%
+631,894
New +$12.5M
BSX icon
45
Boston Scientific
BSX
$65.8B
$13.3M 0.56%
1,043,587
+24,366
+2% +$317K
CLVS
46
DELISTED
Clovis Oncology, Inc.
CLVS
$13M 0.55%
314,952
-178,448
-36% -$9.19M
KPTI icon
47
Karyopharm Therapeutics
KPTI
$168M
$12.5M 0.53%
+17,903
New +$8.33M
DXCM icon
48
DexCom
DXCM
$27.6B
$11.4M 0.48%
1,149,884
+864,500
+303% +$7.66M
TRNX
49
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$11.2M 0.47%
477,829
+35,028
+8% +$728K
HTWR
50
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$10.7M 0.45%
121,127
+21,886
+22% +$1.96M
1
2
3

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Sectoral Asset Management held 74 positions worth $2.36B, down 2.9% from $2.43B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sectoral Asset Management withdrew a net $199M in Q2 2014, closing 10 positions and reducing 22 holdings. Its most notable exit was Aegerion Pharmaceuticals, an estimated $43.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 93% a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in Perrigo worth $51.2M.

  • Sectoral Asset Management's largest Q2 2014 buy was Perrigo: 351,368 shares worth $51.2M.
  • Sectoral Asset Management added most to BioMarin Pharmaceuticals in Q2 2014, an estimated $14.6M increase.
  • Sectoral Asset Management's biggest Q2 2014 reduction was Ironwood Pharmaceuticals, cutting an estimated $55.6M.
  • Sectoral Asset Management fully exited Aegerion Pharmaceuticals in Q2 2014, selling an estimated $43.1M.
  • Sectoral Asset Management's ten largest holdings make up 44% of its $2.36B portfolio in Q2 2014.
  • Sectoral Asset Management opened 10 new positions and closed 10 in Q2 2014.
  • Sectoral Asset Management's portfolio value fell 2.9% quarter-over-quarter to $2.36B.

Based on Sectoral Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.